PNU-282987PNU-282987
MedChemExpress (MCE)
HY-12560A
123464-89-1
99.93%
4°C, sealed storage, away from moisture *In solvent : -80°C, 1 year
-20°C, 6 months (sealed storage, away from moisture)
Room temperature in continental US
may vary elsewhere.
PNU-282987 is a potent α7 nicotinic acetylcholine receptor (nAChR) agonist with an EC50 of 154 nM. PNU-282987 is also a functional antagonist of the 5-HT3 receptor with an IC50 of 4541 nM. PNU-282987 can be used for the research of central and peripheral nervous systems.
PNU-282987 (Compound C7) displaces the R7 selective antagonist methyllycaconitine (MLA) from rat brain homogenates with a Ki of 27 nM[1]. PNU-282987 has α7 nAChR agonist activity with an EC50 of 154 nM[1]. PNU-282987 also has inhibition for the 5-HT3 receptor with an IC50 value of 4541nM[1].
PNU-282987 (Compound C7) (i.v.
1, 3 mg/kg) leads to a reversal of the gating deficit[1]. PNU-282987 (30 μM) evokes currents in rat hippocampal neurons in a concentration-dependent and MLA blockable manner[1].
IC50: 4541nM (5-HT3)
EC50: 154 nM (α7 nAChR)
Ki: 27 nM (R7 MLA)[1] In Vitro PNU-282987 (Compound C7) displaces the R7 selective antagonist methyllycaconitine (MLA) from rat brain homogenates with a Ki of 27 nM[1]. PNU-282987 has α7 nAChR agonist activity with an EC50 of 154 nM[1]. PNU-282987 also has inhibition for the 5-HT3 receptor with an IC50 value of 4541nM[1]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. 0 --> PNU-282987 Related Antibodies
| | | |
| | | | | |
[1]. Alice L Bodnar, et al. Discovery and structure-activity relationship of quinuclidine benzamides as agonists of alpha7 nicotinic acetylcholine receptors. J Med Chem [Content Brief]